76 related articles for article (PubMed ID: 33629937)
1. NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC.
Zhou X; Bao W; Zhang D; Yang Y; Du X; Qiu G
Cancer Biol Ther; 2021 Mar; 22(3):196-203. PubMed ID: 33629937
[TBL] [Abstract][Full Text] [Related]
2. NCK1-AS1 promotes the proliferation, migration, invasion, and EMT of non-small cell lung cancer by regulating the miR-361-5p/ADAM10 axis.
Wu B; Wang Z; Xu H; Chu X; Jiang Q
Histol Histopathol; 2023 Dec; 38(12):1453-1464. PubMed ID: 36912070
[TBL] [Abstract][Full Text] [Related]
3. LINC01936 inhibits the proliferation and metastasis of lung squamous cell carcinoma probably by EMT signaling and immune infiltration.
Tian Q; Liu X; Li A; Wu H; Xie Y; Zhang H; Wu F; Chen Y; Bai C; Zhang X
PeerJ; 2023; 11():e16447. PubMed ID: 38084139
[TBL] [Abstract][Full Text] [Related]
4. Long Intergenic Nonprotein Coding RNA 00174 Aggravates Lung Squamous Cell Carcinoma Progression via MicroRNA-185-5p/Nuclear Factor IX axis.
Gu P; Lin L
Biomed Res Int; 2022; 2022():9490827. PubMed ID: 36060149
[TBL] [Abstract][Full Text] [Related]
5. LncRNA NCK1-AS1 Promotes Cancer Cell Proliferation and Increase Cell Stemness in Urinary Bladder Cancer Patients by Downregulating miR-143.
Qiao Z; Dai H; Zhang Y; Li Q; Zhao M; Yue T
Cancer Manag Res; 2020; 12():1661-1668. PubMed ID: 32184669
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic inhibition of GAS6-AS1/YBX1/MYC axis suppresses cell propagation and disease progression of acute myeloid leukemia.
Zhou H; Liu W; Zhou Y; Hong Z; Ni J; Zhang X; Li Z; Li M; He W; Zhang D; Chen X; Zhu J
J Exp Clin Cancer Res; 2021 Nov; 40(1):353. PubMed ID: 34753494
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of EpCAM-specific exosomal lncRNAs as potential diagnostic biomarkers for lung cancer using droplet digital PCR.
Shen X; Yang Y; Chen Y; Zhou C; Zhao X; Li N; Lou C; Huang Y; Tian D; Shen Y; Meng X
J Mol Med (Berl); 2022 Jan; 100(1):87-100. PubMed ID: 34651202
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic zinc finger protein ZNF322A promotes stem cell-like properties in lung cancer through transcriptional suppression of c-Myc expression.
Jen J; Liu CY; Chen YT; Wu LT; Shieh YC; Lai WW; Wang YC
Cell Death Differ; 2019 Jul; 26(7):1283-1298. PubMed ID: 30258097
[TBL] [Abstract][Full Text] [Related]
9. LINE-1 Retrotransposition Promotes the Development and Progression of Lung Squamous Cell Carcinoma by Disrupting the Tumor-Suppressor Gene FGGY.
Zhang R; Zhang F; Sun Z; Liu P; Zhang X; Ye Y; Cai B; Walsh MJ; Ren X; Hao X; Zhang W; Yu J
Cancer Res; 2019 Sep; 79(17):4453-4465. PubMed ID: 31289132
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of STEAP3 in lung squamous cell carcinoma: Regulating EGFR to affect cell proliferation and ferroptosis.
Shi H; Lei S; Xiong L; Du S; Shi Y
Arch Biochem Biophys; 2024 Jan; 751():109842. PubMed ID: 38040224
[TBL] [Abstract][Full Text] [Related]
11. PLAU, transcriptionally negatively regulated by GATA6, promotes lung squamous carcinoma cell proliferation and migration.
Guo J; Wang H; Huang C; Lai C; Shang W; Luo S; Chen L
Biochim Biophys Acta Mol Cell Res; 2024 May; 1871(5):119744. PubMed ID: 38702016
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification.
Liu X; Chen W; Qi Y; Zhu Y
Evid Based Complement Alternat Med; 2022; 2022():5702014. PubMed ID: 36159563
[TBL] [Abstract][Full Text] [Related]
13. KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition.
Pan Y; Han H; Hu H; Wang H; Song Y; Hao Y; Tong X; Patel AS; Misirlioglu S; Tang S; Huang HY; Geng K; Chen T; Karatza A; Sherman F; Labbe KE; Yang F; Chafitz A; Peng C; Guo C; Moreira AL; Velcheti V; Lau SCM; Sui P; Chen H; Diehl JA; Rustgi AK; Bass AJ; Poirier JT; Zhang X; Ji H; Zhang H; Wong KK
Cancer Cell; 2023 Jan; 41(1):88-105.e8. PubMed ID: 36525973
[TBL] [Abstract][Full Text] [Related]
14. USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity.
Kwon J; Zhang J; Mok B; Allsup S; Kim C; Toretsky J; Han C
Mol Cancer; 2023 Dec; 22(1):204. PubMed ID: 38093367
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitylase USP31 Induces Autophagy and Promotes the Progression in Lung Squamous Cell Carcinoma Cells by Stabilizing E2F1 Expression.
Liang W; Yang M; Wang X; Qian Y; Gao R; Shi Y; Shi X; Shi L; Xu T; Zhang Q
Curr Cancer Drug Targets; 2024 Jan; ():. PubMed ID: 38204265
[TBL] [Abstract][Full Text] [Related]
16. c-Rel is a Novel Oncogene in Lung Squamous Cell Carcinoma Regulating Cell Proliferation and Migration.
Luo R; Liu Q; Hu Z; Dai W; Huang S; Xie J; Wei S; Lin C
J Cancer; 2024; 15(8):2329-2339. PubMed ID: 38495491
[TBL] [Abstract][Full Text] [Related]
17. Correction: Long noncoding RNA SH3PXD2A-AS1 promotes NSCLC proliferation and accelerates cell cycle progression by interacting with DHX9.
Zhou Y; Yong H; Cui W; Chu S; Li M; Li Z; Bai J; Zhang H
Cell Death Discov; 2023 Aug; 9(1):305. PubMed ID: 37604866
[No Abstract] [Full Text] [Related]
18. Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project.
Finn SP; Addeo A; Dafni U; Thunnissen E; Bubendorf L; Madsen LB; Biernat W; Verbeken E; Hernandez-Losa J; Marchetti A; Cheney R; Warth A; Speel EM; Quinn AM; Monkhorst K; Jantus-Lewintre E; Tischler V; Marti N; Dimopoulou G; Molina-Vila MA; Kammler R; Kerr KM; Peters S; Stahel RA;
J Thorac Oncol; 2021 Jun; 16(6):990-1002. PubMed ID: 33647504
[TBL] [Abstract][Full Text] [Related]
19. Crizotinib in Patients With MET-Amplified NSCLC.
Camidge DR; Otterson GA; Clark JW; Ignatius Ou SH; Weiss J; Ades S; Shapiro GI; Socinski MA; Murphy DA; Conte U; Tang Y; Wang SC; Wilner KD; Villaruz LC
J Thorac Oncol; 2021 Jun; 16(6):1017-1029. PubMed ID: 33676017
[TBL] [Abstract][Full Text] [Related]
20. LINC01089 functions as a ceRNA for miR-152-3p to inhibit non-small lung cancer progression through regulating PTEN.
Zhang H; Zhang H; Li X; Huang S; Guo Q; Geng D
Cancer Cell Int; 2021 Mar; 21(1):143. PubMed ID: 33653358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
